Get started
Work

PCN40 Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma: DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma

Year: 2020
Type: conference-abstract
DOI: 10.1016/j.jval.2020.08.177
Authors: M. Mandala, A. Arance, R. Dummer, P.A. Ascierto, H. Gogas, G. Liszkay, C. Garbe, D. Schadendorf, I. Krajsová, R. Gutzmer, V. Chiarion Sileni, C. Dutriaux, C. Loquai, A. Tadmouri, M.D. Pickard, A. Gollerkeri, C. Robert, K.T. Flaherty
Institutions: Ospedale Papa Giovanni XXIII, Hospital Clínic de Barcelona, University Hospital Zurich, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", National and Kapodistrian University of Athens, National Institute of Oncology, University of Tübingen, Essen University Hospital, Deutsches Konsortium für Translationale Krebsforschung, Charles University, Medizinische Hochschule Hannover, Istituto Oncologico Veneto, Hôpital Saint-André, University Medical Center of the Johannes Gutenberg University Mainz, Pierre Fabre (France), Pfizer (United States), Institut Gustave Roussy, Massachusetts General Hospital
Language: English
Open Access status: bronze
OpenAlex ID: W3111974592
Cites:
Cited by:
Related to: 10